Skip to content

Enovis ENOV Prevention & Recovery — Provisions

Other segment segments

Reconstructive
$1.3M+30.0%

Similar metrics at other companies

Albany International Inc. logo
AINProvision/(recovery) for credit losses from uncollected receivables and contract assets
-$207K-177%
DENTSPLY SIRONA logo
XRAYConnected Technology Solutions — Provisions
$23M+1,050%
Ceco Environmental logo
CECOProvision Recovery For Credit Loss
-$1.52M-285%
Organon logo
OGNU.S. — Provision
$861.75M+14.0%
CNH Industrial N.V. logo
CNHProvisions
-$120M+19.5%
DENTSPLY SIRONA logo
XRAYOrthodontic and Implant Solutions — Provisions
$21M+2,000%

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-28.4%
Enterprise value$2.55B-17.1%
P/S0.5×-0.3×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:RestructuringSettlementAndImpairmentProvisions.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's prevention & recovery — provisions.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's prevention & recovery — provisions?
Enovis (ENOV) reported prevention & recovery — provisions of $1.4M in Q1 2026.
What does prevention & recovery — provisions mean?
The amount set aside by the Prevention & Recovery segment to cover anticipated future liabilities, such as warranty claims, legal contingencies, or inventory obsolescence. This metric reflects the segment's proactive management of operational and legal risks associated with its medical device portfolio.